<DOC>
	<DOC>NCT00576342</DOC>
	<brief_summary>In this randomized crossover study, patients will receive a single drop of two test articles and assess comfort.</brief_summary>
	<brief_title>Patient Preference Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Sign informed consent; Diagnosis of glaucoma or ocular hypertension; On a stable regimen of any intraocular pressure (IOP) lowering medication (monotherapy); IOP for which, in the opinion of the investigator, participation in the study does not present a risk to ocular health; Other protocoldefined inclusion criteria may apply. Best corrected visual acuity worse than 0.60 logMAR (20/80 Snellen) in either eye; Pregnant, nursing, or not using highly effective birth control methods; Use of oral or topical corticosteroids within 30 days of the Screening Visit and during the course of the study; History of bronchial asthma or severe chronic obstructive pulmonary disease; Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>